|By Marketwired .||
|June 19, 2014 06:30 AM EDT||
DRAPER, UT -- (Marketwired) -- 06/19/14 -- Nutranomics (OTCBB: NNRX), U.S. manufacturer of high quality, whole-food based vitamins and supplements designed to support people aiming for a healthy lifestyle and those suffering from various diseases, has partnered with investment guru Stonegate.
Stonegate is a full-service investment banking boutique dedicated to serving the specialized needs of small-cap public companies. Stonegate provides research, sales and trading, corporate finance, strategic advisory and investor relations services to its select group of clients. We work with the leading institutional investors in the U.S. and Europe who are seeking high quality investment opportunities in the small cap market place.
As ninety-five percent of all multi-vitamins on the market today are isolated and/or synthetic, more and more people are searching for a natural, healthy alternative. Nutranomics offers an effective market alternative, one focused on total overall health.
To learn more about Nutranomics supplements, visit http://www.nutranomics.com
About Nutranomics: Nutranomics has been at the forefront of research and development of nutritional food products since its inception in 1995. At present, we are one of the leading brands in the manufacture of safe, high quality vitamins and supplements distributed in various countries around the world. More than just a health supplement manufacturer, we also see our role in supporting the worldwide community of people aiming for a healthy lifestyle.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's expectation that the products mentioned will continue to be steady sellers for the client and that the client will place additional product re-orders. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.
These statements have not been evaluated by the Food and Drug Administration. The company's products are not intended to diagnose, treat, cure or prevent any disease.
Please direct inquiries to:
Dec. 4, 2016 09:00 AM EST Reads: 542
Dec. 4, 2016 08:45 AM EST Reads: 785
Dec. 4, 2016 08:30 AM EST Reads: 969
Dec. 4, 2016 08:30 AM EST Reads: 760
Dec. 4, 2016 08:15 AM EST Reads: 749
Dec. 4, 2016 08:15 AM EST Reads: 705
Dec. 4, 2016 08:00 AM EST Reads: 804
Dec. 4, 2016 08:00 AM EST Reads: 689
Dec. 4, 2016 06:45 AM EST Reads: 1,228
Dec. 4, 2016 06:15 AM EST Reads: 6,971
Dec. 4, 2016 05:30 AM EST Reads: 1,753
More and more companies are looking to microservices as an architectural pattern for breaking apart applications into more manageable pieces so that agile teams can deliver new features quicker and more effectively. What this pattern has done more than anything to date is spark organizational transformations, setting the foundation for future application development. In practice, however, there are a number of considerations to make that go beyond simply “build, ship, and run,” which changes how...
Dec. 4, 2016 04:45 AM EST Reads: 4,968
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
Dec. 4, 2016 04:30 AM EST Reads: 1,554
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Phil Hombledal, Solution Architect at CollabNet, discussed how customers are able to achieve a level of transparency that e...
Dec. 4, 2016 04:30 AM EST Reads: 876
Amazon has gradually rolled out parts of its IoT offerings, but these are just the tip of the iceberg. In addition to optimizing their backend AWS offerings, Amazon is laying the ground work to be a major force in IoT - especially in the connected home and office. In his session at @ThingsExpo, Chris Kocher, founder and managing director of Grey Heron, explained how Amazon is extending its reach to become a major force in IoT by building on its dominant cloud IoT platform, its Dash Button strat...
Dec. 4, 2016 04:00 AM EST Reads: 6,226